DexCom, Inc. (DXCM)

Nasdaq · Healthcare · Medical Devices
$79.32-1.08%As of 2026-11-22 · USD
Last session low $78.75Last session high $81.58
52-week low $56.7252-week high $92.59
Market cap
$29.58B
Sector
Healthcare
P/E (TTM)
31.2x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)45.3In the neutral range (30 to 70)
MACD (12, 26, 9)-0.68Above its signal line (-0.70); histogram 0.02
Bollinger %B (20, 2)27%Inside the bands (76.74 to 86.34)
SMA 2081.54Price is 2.7% below
SMA 5083.96Price is 5.5% below
SMA 20075.32Price is 5.3% above
ATR (20)3.53% of priceAverage true range per day
52-week position63%In the middle of the 56.72 to 92.59 range

About DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.

Insider filings, 90 daysNo purchases and 8 sales (about $1.9M).
Latest fiscal yearEnded 2025-12-31: revenue of $4.66B and an operating margin of 19.6%.

More in Medical Devices